Latest Breaking News On - Prospective study - Page 8 : comparemela.com

Bionano Announces Presentation of OGM Utility Across Key Research Applications at the Association for Molecular Pathology Annual Meeting

Bionano Announces Presentation of OGM Utility Across Key Research Applications at the Association for Molecular Pathology Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSalt lake citySusan crockerAlka chaubeyRavindra kolheMiriam bornhorstOkechukwu nwogboPanieh terrafErik holmlinDavid holmesScott ryallDaniel saulAlex hastieAdam smithMark oldakowskiDarisha jiandani

Artificial heart maker Carmat announces progress on its Aeson device

PARIS (Reuters) -French artificial heart maker Carmat said on Monday it had implanted seven of its Aeson devices as part of a clinical study in Paris, sending its shares up almost 8%. “This ramp-up is the result of growing experience in patient selection and attests to the steep learning curve of the surgical procedure,” Professor Christian Latremouille, director of surgical affairs at Carmat, said in a press release. The clinical study, called EFICAS, is a prospective study designed to include 52 patients eligible for transplants, currently enrolled by a network of six French cardiology centres, Carmat said.

France generalMichal aleksandrowiczChristian latremouilleSudip kar guptaJanane venkatramanSurgical affairs at carmatProfessor christian latremouilleSurgical affairsJamie freedArtificial heartProspective studyClinical studyProfessor christian latremouilleHeart transplant

CARMAT Presented Its Progress on the EFICAS Clinical Study at the 36th Journées de La Pitié in Paris

PARIS, October 23, 2023 Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aimed at providing a therapeutic alternative for patients suffering from advanced biventricular heart failure (the "Company" or "CARMAT"), announces that it has presented its progress on the EFICAS clinical trial at the 36th "Journées de La Pitié" national conference on heart and lung transplantation and circulatory assistance, organized by the cardi

United statesBois darcyFrance generalCaroline carmagnolChristian latrEnregistrement universelFood drug administrationSurgical affairsEuropean unionLille regional university hospitalRegulatory newsLouis pradelHospices civils de lyonFrench medtechEarly feasibility studyEuronext growth

Mental health issues in Latinx middle schoolers may increase risk of sleep problems, obesity and unhealthy behaviors

Mental health issues in Latinx middle schoolers may increase risk of sleep problems, obesity and unhealthy behaviors
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Kathleenm rocheHuman servicesJournal of adolescent healthGw milken institute school of public healthGeorge washington universityUs department of healthMental health during early adolescenceInstitute schoolPublic healthHealth during early adolescenceLater cardiometabolic riskProspective studyAdolescent health

Premia Spine Announces New Technology Add-On Payment for TOP™ System

Premia Spine Announces New Technology Add-On Payment for TOP™ System
orthospinenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from orthospinenews.com Daily Mail and Mail on Sunday newspapers.

United statesLos angelesRon sacherPeter wehrlyDrug administrationJournal of health economicsTechnology paymentNeurosurgery spine groupBreakthrough technologyOutcomes researchCenters for medicare medicaid servicesFirst facet replacementTransform spinal treatmentSpinal stenosisSuperior alternativeTraditional fusion